» Articles » PMID: 19956772

Single-cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses

Overview
Journal PLoS One
Date 2009 Dec 4
PMID 19956772
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Signal Transducer and Activator of Transcription 5 (STAT5) plays critical roles in normal and leukemic hematopoiesis. However, the manner in which STAT5 responds to early-acting and lineage-restricted cytokines, particularly in leukemic stem/progenitor cells, is largely unknown.

Methodology/principal Findings: We optimized a multiparametric flow cytometry protocol to analyze STAT5 phosphorylation upon cytokine stimulation in stem and progenitor cell compartments at a single-cell level. In normal cord blood (CB) cells, STAT5 phosphorylation was efficiently induced by TPO, IL-3 and GM-CSF within CD34(+)CD38(-) hematopoietic stem cells (HSCs). EPO- and SCF-induced STAT5 phosphorylation was largely restricted to the megakaryocyte-erythroid progenitor (MEP) compartment, while G-CSF as well IL-3 and GM-CSF were most efficient in inducing STAT5 phosphorylation in the myeloid progenitor compartments. Strikingly, mobilized adult peripheral blood (PB) CD34(+) cells responded much less efficiently to cytokine-induced STAT5 activation, with the exception of TPO. In leukemic stem and progenitor cells, highly distinct cytokine responses were observed, differing significantly from their normal counterparts. These responses could not be predicted by the expression level of cytokine receptors. Also, heterogeneity existed in cytokine requirements for long-term expansion of AML CD34(+) cells on stroma.

Conclusions/significance: In conclusion, our optimized multiparametric flow cytometry protocols allow the analysis of signal transduction at the single cell level in normal and leukemic stem and progenitor cells. Our study demonstrates highly distinctive cytokine responses in STAT5 phosphorylation in both normal and leukemic stem/progenitor cells.

Citing Articles

Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia.

Li Y, Seet C, Mack R, Joshi K, Runde A, Hagen P Stem Cell Reports. 2023; 19(1):100-111.

PMID: 38101400 PMC: 10828676. DOI: 10.1016/j.stemcr.2023.11.003.


Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.

Seipel K, Graber C, Fluckiger L, Bacher U, Pabst T Int J Mol Sci. 2021; 22(15).

PMID: 34360855 PMC: 8347059. DOI: 10.3390/ijms22158092.


JAK-STAT in Early Hematopoiesis and Leukemia.

Fasouli E, Katsantoni E Front Cell Dev Biol. 2021; 9:669363.

PMID: 34055801 PMC: 8160090. DOI: 10.3389/fcell.2021.669363.


Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.

Berrazouane S, Boisvert M, Salti S, Mourad W, Al-Daccak R, Barabe F Cell Death Dis. 2019; 10(5):357.

PMID: 31043590 PMC: 6494825. DOI: 10.1038/s41419-019-1593-2.


Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis.

Abderrazak A, El Azreq M, Naci D, Fortin P, Aoudjit F Front Immunol. 2018; 9:2269.

PMID: 30374344 PMC: 6197073. DOI: 10.3389/fimmu.2018.02269.


References
1.
Socolovsky M, Nam H, Fleming M, Haase V, Brugnara C, Lodish H . Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood. 2001; 98(12):3261-73. DOI: 10.1182/blood.v98.12.3261. View

2.
Krebs D, Hilton D . SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001; 19(5):378-87. DOI: 10.1634/stemcells.19-5-378. View

3.
Socolovsky M, Fallon A, Wang S, Brugnara C, Lodish H . Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 1999; 98(2):181-91. DOI: 10.1016/s0092-8674(00)81013-2. View

4.
Bunting K . STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci. 2007; 12:2807-20. DOI: 10.2741/2274. View

5.
Nosaka T, Kawashima T, Misawa K, Ikuta K, Mui A, Kitamura T . STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 1999; 18(17):4754-65. PMC: 1171548. DOI: 10.1093/emboj/18.17.4754. View